
Leo Pharma has decided on the person who will replace Kim Kjøller’s position in the pharmaceutical company, as he will be taking up the position of CEO at Union Therapeutics starting next year.
The new man leading Leo’s research and developmental work is Jörg Möller from Germany, who was fetched from Bayer Pharma, where he has held a similar position in the German pharmaceutical firm’s executive group since January 2018.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app